UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Going viral with cancer immunotherapy

Nature reviews. Cancer, 2014-08, Vol.14 (8), p.559-567

2014

Volltextzugriff (PDF)

Characterizing Cellular Responses During Oncolytic Maraba Virus Infection

International journal of molecular sciences, 2019-01, Vol.20 (3), p.580

2019

Volltextzugriff (PDF)

Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell Death

Cancer cell, 2011-10, Vol.20 (4), p.443-456

2011

Volltextzugriff (PDF)

An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative Stress

Molecular cell, 2003-03, Vol.11 (3), p.619-633

2003

Volltextzugriff (PDF)

Maraba Virus as a Potent Oncolytic Vaccine Vector

Molecular therapy, 2014-02, Vol.22 (2), p.420-429

2014

Volltextzugriff (PDF)

Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity

The Journal of clinical investigation, 2019-02, Vol.129 (2), p.518-530

2019

Volltextzugriff (PDF)

Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials

Oncoimmunology, 2019-01, Vol.8 (1), p.e1512329-e1512329

2019

Volltextzugriff (PDF)

Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood Flow

Molecular therapy, 2007-09, Vol.15 (9), p.1686-1693

2007

Volltextzugriff (PDF)

Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy

Science translational medicine, 2018-01, Vol.10 (422)

2018

Volltextzugriff (PDF)

Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy

Viruses, 2016-02, Vol.8 (2), p.45

2016

Volltextzugriff (PDF)

Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer

Frontiers in immunology, 2022-11, Vol.13, p.1029269-1029269

2022

Volltextzugriff (PDF)

Identification of Genetically Modified Maraba Virus as an Oncolytic Rhabdovirus

Molecular therapy, 2010-08, Vol.18 (8), p.1440-1449

2010

Volltextzugriff (PDF)

Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide

Clinical cancer research, 2009-04, Vol.15 (8), p.2777-2788

2009

Volltextzugriff (PDF)

Abstract 1473: Dual oncolytic viral immunotherapy generates large polyfunctional tumour-specific CD8 + T cell responses that infiltrate immunosuppressive tumors

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1473-1473

Stojdl, David

2019

Volltextzugriff (PDF)

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

Cancer cell, 2003-10, Vol.4 (4), p.263-275

2003

Volltextzugriff (PDF)

Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development

Molecular therapy. Oncolytics, 2021-09, Vol.22, p.85-97

2021

Volltextzugriff (PDF)

Codelivery of mRNA with α‑Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration

ACS omega, 2019-08, Vol.4 (8), p.13015-13026

2019

Volltextzugriff (PDF)

Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis

Proceedings of the National Academy of Sciences - PNAS, 2008-09, Vol.105 (39), p.14981-14986

2008

Volltextzugriff (PDF)

Vesicular stomatitis virus: re-inventing the bullet

Trends in molecular medicine, 2004-05, Vol.10 (5), p.210-216

2004

Volltextzugriff (PDF)

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

Nature medicine, 2000-07, Vol.6 (7), p.821-825

2000

Volltextzugriff (PDF)

Transforming the prostatic tumor microenvironment with oncolytic virotherapy

Oncoimmunology, 2018-07, Vol.7 (7), p.e1445459-e1445459

2018

Volltextzugriff (PDF)

Molecular Pathways: Multimodal Cancer-Killing Mechanisms Employed by Oncolytic Vesiculoviruses

Clinical cancer research, 2013-02, Vol.19 (4), p.758-763

2013

Volltextzugriff (PDF)

Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential

BMC cancer, 2017-08, Vol.17 (1), p.594-594, Article 594

2017

Volltextzugriff (PDF)

Maraba MG1 Virus Enhances Natural Killer Cell Function via Conventional Dendritic Cells to Reduce Postoperative Metastatic Disease

Molecular therapy, 2014-07, Vol.22 (7), p.1320-1332

2014

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(68)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Going viral with cancer immunotherapy

Characterizing Cellular Responses During Oncolytic Maraba Virus Infection

Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell Death

An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative Stress

Maraba Virus as a Potent Oncolytic Vaccine Vector

Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity

Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials

Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood Flow

Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy

Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy

Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer

Identification of Genetically Modified Maraba Virus as an Oncolytic Rhabdovirus

Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide

Abstract 1473: Dual oncolytic viral immunotherapy generates large polyfunctional tumour-specific CD8 + T cell responses that infiltrate immunosuppressive tumors

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development

Codelivery of mRNA with α‑Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration

Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis

Vesicular stomatitis virus: re-inventing the bullet

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

Transforming the prostatic tumor microenvironment with oncolytic virotherapy

Molecular Pathways: Multimodal Cancer-Killing Mechanisms Employed by Oncolytic Vesiculoviruses

Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential

Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity

Maraba MG1 Virus Enhances Natural Killer Cell Function via Conventional Dendritic Cells to Reduce Postoperative Metastatic Disease

Suchergebnisse filtern